Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062822-23-000047
Filing Date
2023-08-04
Accepted
2023-08-04 07:07:53
Documents
46
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lxrx-20230630.htm   iXBRL 10-Q 692249
2 EX-31.1 exh311certificationofprinc.htm EX-31.1 9555
3 EX-31.2 exh312certificationofprinc.htm EX-31.2 9371
4 EX-32.1 exh321certificationofprinc.htm EX-32.1 6055
  Complete submission text file 0001062822-23-000047.txt   3867184

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20230630.xsd EX-101.SCH 30833
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lxrx-20230630_cal.xml EX-101.CAL 35996
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lxrx-20230630_def.xml EX-101.DEF 125594
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20230630_lab.xml EX-101.LAB 380999
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20230630_pre.xml EX-101.PRE 228844
40 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20230630_htm.xml XML 476138
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30111 | Film No.: 231142140
SIC: 2834 Pharmaceutical Preparations